DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Poordad F, Schiff E, Vierling JM. et al.
Daclatasvir, Sofosbuvir, and Ribavirin Combination for HCV Patients with Advanced Cirrhosis or Post-transplant Recurrence: Final Results of the ALLY-1 Study.
American Journal of Gastroenterology 2016;
111: S346-S346
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.